Page last updated: 2024-08-17

medroxyprogesterone acetate and Meningioma

medroxyprogesterone acetate has been researched along with Meningioma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altinoz, MA; Elmaci, I; Ozpinar, A1
Hensiek, AE; Hill, JT; Kellerman, AJ1
Markwalder, TM; Waelti, ER1
Haltia, M; Jääskeläinen, J; Kärkkäinen, J; Laasonen, E; Troupp, H1
König, MP; Markwalder, TM; Waelti, E1
Gerber, HA; Markwalder, RV; Markwalder, TM; Schaffner, T; Waelti, E1

Reviews

1 review(s) available for medroxyprogesterone acetate and Meningioma

ArticleYear
Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
    Neurosurgical review, 2019, Volume: 42, Issue:2

    Topics: Animals; Antineoplastic Agents, Hormonal; Brain Neoplasms; Female; Glioma; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Meningioma; Mifepristone; Norpregnadienes; Progesterone; Progestins; Receptors, Progesterone

2019

Other Studies

5 other study(ies) available for medroxyprogesterone acetate and Meningioma

ArticleYear
Spontaneous regression of a solitary cerebral metastases in renal carcinoma followed by meningioma development under medroxyprogesterone acetate therapy.
    British journal of neurosurgery, 2000, Volume: 14, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Brain Neoplasms; Carcinoma, Renal Cell; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Medroxyprogesterone Acetate; Meningioma; Neoplasm Regression, Spontaneous; Neoplasms, Second Primary

2000
Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture.
    Surgical neurology, 1989, Volume: 31, Issue:2

    Topics: Antigens, Surface; Cell Division; Culture Techniques; Endocrine Glands; Humans; Immunohistochemistry; Ki-67 Antigen; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Receptors, Progesterone; Tumor Cells, Cultured

1989
Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.
    Acta neurochirurgica, 1986, Volume: 80, Issue:1-2

    Topics: Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Middle Aged; Pilot Projects; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed

1986
Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosols.
    Surgical neurology, 1987, Volume: 28, Issue:1

    Topics: Cytosol; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Middle Aged; Pilot Projects; Receptors, Estrogen; Receptors, Progesterone

1987
Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67.
    Surgical neurology, 1988, Volume: 30, Issue:2

    Topics: Antibodies, Monoclonal; Drug Evaluation; Growth Substances; Humans; Immunoenzyme Techniques; Immunohistochemistry; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Neoplasm Proteins; Peptides; Preoperative Care; Receptors, Progesterone; Reoperation; Time Factors; Transforming Growth Factors

1988